Skip to main content
. 2020 May 4;10(5):48. doi: 10.1038/s41408-020-0318-1

Fig. 1. Survival outcomes by TKI use.

Fig. 1

a, b Overall survival and relapse free survival for all patients treated with high intensity chemotherapy by TKI use, without censoring to allogeneic hematopoietic stem cell transplantation. c, d Overall survival and relapse free survival for all patients treated with low intensity chemotherapy by TKI usage, without censoring to allogeneic hematopoietic stem cell transplantation.